Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile

I'rom Group Co Company

2372.T
JP3105170009

Price

2,774.00
Today +/-
-0.01
Today %
-0.07 %
P

I'rom Group Co stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the I'rom Group Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the I'rom Group Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the I'rom Group Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze I'rom Group Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

I'rom Group Co Stock Price History

DateI'rom Group Co Price
10/25/20242,774.00 undefined
10/24/20242,776.00 undefined
10/23/20242,778.00 undefined
10/22/20242,779.00 undefined
10/21/20242,781.00 undefined
10/18/20242,781.00 undefined
10/17/20242,782.00 undefined
10/16/20242,781.00 undefined
10/15/20242,780.00 undefined
10/11/20242,780.00 undefined
10/10/20242,781.00 undefined
10/9/20242,786.00 undefined
10/8/20242,778.00 undefined
10/7/20242,786.00 undefined
10/4/20242,785.00 undefined
10/3/20242,784.00 undefined
10/2/20242,776.00 undefined
10/1/20242,782.00 undefined
9/30/20242,775.00 undefined

I'rom Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into I'rom Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by I'rom Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects I'rom Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of I'rom Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into I'rom Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing I'rom Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on I'rom Group Co’s growth potential.

I'rom Group Co Revenue, EBIT and net profit per share

DateI'rom Group Co RevenueI'rom Group Co EBITI'rom Group Co Net Income
2026e15.76 B undefined0 undefined2.32 B undefined
2025e15.27 B undefined0 undefined2.21 B undefined
202417.74 B undefined1.13 B undefined1.42 B undefined
202318.35 B undefined3.64 B undefined2.54 B undefined
202215.69 B undefined2.76 B undefined1.96 B undefined
202112.91 B undefined1.07 B undefined1.37 B undefined
202010.59 B undefined1.21 B undefined1.24 B undefined
201910.58 B undefined1.22 B undefined912 M undefined
20188.62 B undefined1.04 B undefined1.56 B undefined
20174.89 B undefined212 M undefined204 M undefined
20164.11 B undefined-480 M undefined-868 M undefined
20154.13 B undefined-772 M undefined-606 M undefined
20144.01 B undefined-402 M undefined-294 M undefined
20136.7 B undefined369 M undefined1.75 B undefined
201211.02 B undefined-433 M undefined-364 M undefined
201113.99 B undefined343 M undefined226 M undefined
201013.82 B undefined-159 M undefined-731 M undefined
200914.48 B undefined57 M undefined-10.88 B undefined
200813.73 B undefined-251 M undefined-932 M undefined
200714.89 B undefined-1.29 B undefined-168 M undefined
200612.37 B undefined209 M undefined137 M undefined
20054.6 B undefined505 M undefined-84 M undefined

I'rom Group Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e
2.543.654.612.3714.8913.7314.4813.8213.9911.026.74.014.134.114.898.6210.5810.5912.9115.6918.3517.7415.2715.76
-43.5925.79169.1620.39-7.815.47-4.581.27-21.24-39.15-40.173.07-0.4818.8676.3022.700.1421.8421.5916.94-3.33-13.913.20
65.1768.5738.2829.1425.4229.0529.7928.1527.5823.8631.3526.6820.0527.2536.8540.7338.3340.2234.3246.1449.4042.31--
1.662.511.763.63.793.994.313.893.862.632.11.070.831.121.83.514.064.264.437.249.077.5100
1.011.590.510.21-1.29-0.250.06-0.160.34-0.430.37-0.4-0.77-0.480.211.041.221.211.072.763.641.1300
39.6643.4210.991.69-8.63-1.830.39-1.152.45-3.935.50-10.02-18.67-11.674.3412.1111.5211.398.2817.6119.836.39--
0.50.7-0.080.14-0.17-0.93-10.88-0.730.23-0.361.75-0.29-0.61-0.870.21.560.911.241.371.962.541.422.212.32
-39.12-112.05-263.10-222.63454.761,067.81-93.28-130.92-261.06-581.04-116.79106.1243.23-123.50663.73-41.4635.5311.0842.8329.63-44.3456.335.06
------------------------
------------------------
8891099999991010.2610.6110.9111.7912.0511.8512.0512.112.112.1100
------------------------
Details

Keystats

Revenue and Growth

The I'rom Group Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the I'rom Group Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (B)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                           
1.122.281.416.45.432.741.521.090.70.81.931.591.60.860.542.62.962.454.076.49.397.24
0.070.751.232.382.992.44-0.242.442.720.591.050.620.780.861.421.571.812.152.782.62.994.08
0.220.540.563.396.17.223.740.830.8600.350.20.240.190.120.10.140.340.770.790.690.63
0.671.280.251.871.674.241.991.541.690.50.610.670.80.881.931.91.161.572.192.630.810.72
0.070.190.581.141.9910.710.920.870.630.310.490.450.230.290.540.780.480.960.721.452.77
2.165.054.0215.1818.1817.637.726.826.832.524.233.573.873.024.36.716.856.9910.7613.1415.3315.44
0.590.782.115.964.644.136.015.234.92.640.870.550.630.681.421.363.14.65.537.981315.72
1.210.61.292.262.321.520.240.140.140.010.180.560.720.750.651.191.350.761.492.452.962.24
0000.060.250.183.845.426.154.720.981.030.3300.460.080.330.50.510.550.540.23
0381462571981571114972381133342962204113138754446
0001.461.010.70.410.120000.480.530.481.181.060.960.971.121.050.920.84
0.320.70.881.71.712.1-1.94-3.85-4.92-3.96-0.47-0.290.430.260.290.860.911.251.441.362.342.62
2.112.084.2811.5910.188.838.727.186.323.471.62.462.972.474.224.566.668.1110.1313.4519.821.71
4.267.138.326.7628.3626.4616.451413.1565.836.036.845.58.5211.2713.5115.1120.8926.5935.1337.15
                                           
0.051.51.56.286.296.296.296.296.296.296.292.693.043.043.383.513.523.723.873.883.93.9
0.112.792.797.577.587.587.587.587.587.587.580.65111.331.11.11.311.451.471.51.5
0.681.371.221.260.94-0.08-10.74-11.44-11.22-11.59-9.841.040.52-0.41-0.181.251.932.763.655.127.047.6
0000000001017113-11-54-82-200-28403558
4-34177-57-37-10-140060-30-124-5718-418768107140
0.845.655.5115.1314.8113.723.092.412.632.274.024.454.563.634.45.756.487.599.1210.5712.5713.2
0.050.050.31.721.531.261.511.431.730.50.090.050.060.090.080.090.140.210.410.250.580.65
5765974343437380000001359300000
1.841.261.442.722.252.121.721.661.221.260.951.031.051.522.131.290.891.572.063.132.95
0.8500.84.678.057.456.885.815.271.18000.290.150.640.681.331.052.653.656.366.36
0.13000.090.020.670.660.520.190000.070.10.140.220.540.91.111.482.322.55
2.871.322.559.2511.9311.5111.099.518.892.91.3511.461.392.363.253.393.055.737.4412.3912.52
0.46000.7400.060.150.130000.040.190.381.191.533.354.165.498.279.8311.05
1001901911721711721728143531639161551770130
0.10.160.231.0910.921.871.711.420.740.420.440.560.480.480.730.710.710.890.720.760.81
0.560.160.232.021.191.152.22.011.590.820.460.540.770.91.682.284.064.896.458.9910.5911.86
3.431.472.7811.2713.1112.6613.2911.5210.483.721.811.542.232.294.055.527.457.9412.1816.4322.9824.38
4.277.138.2926.427.9226.3816.3813.9313.1165.8366.795.928.4411.2713.9315.5321.32735.5537.57
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of I'rom Group Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand I'rom Group Co's financial health and stability.

Assets

I'rom Group Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that I'rom Group Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of I'rom Group Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into I'rom Group Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.991.410.410.470.16-0.72-10.24-0.680.11-0.141.79-0.33-0.6-0.810.281.821.181.131.692.593.34
17232937976988589978856229911176115198208278214363495607797
000000000000000000000
-1.05-2.12-0.32-2.64-5.22-1.96-1.671.01-0.160.16-1.060.26-0.10.13-1.30.73-0.93-0.83-1.03-0.54-0.61
0.020.080.04-0.15-0.970.4510.23-0.780.21-0.42-1.460.1-0.20.21-0.01-0.960.04-0.02-0.78-0.020.03
182322494910710714111987805112443478878102142
308614445799575879349-36255-193135-33162010732029481491749
-0.02-0.610.16-1.94-5.26-1.34-0.780.350.72-0.1-0.620.1-0.78-0.27-0.831.880.50.640.382.633.56
-544-205-1,031-1,675-1,647-1,112-129-224-133-253-469-147-11-108-635-89-1,867-1,401-2,636-2,042-4,167
-1.16-0.91-1.81-3.911.09-1.780.610.170.042.532.87-0.42-0.47-0.37-1.650.09-2.22-1.54-1.47-2.92-4.84
-0.62-0.7-0.78-2.232.74-0.670.740.40.182.783.34-0.27-0.46-0.26-1.010.18-0.35-0.141.17-0.88-0.68
000000000000000000000
0.77-1.440.81.313.210.04-0.47-1.25-0.85-2.3-1.18-0.010.50.051.360.442.780.232.953.164.86
0.114.1409.510.01000000-0.010.68-00.690.25-0.390.390.2800
0.882.680.7810.743.29-0.05-0.56-1.25-0.85-2.3-1.180.031.24-0.082.03-0.012.150.262.752.684.26
00601700000003858-123-17-587-7-12-9-7-4
0-18-27-82-91-92-9200000000-114-232-349-475-480-603
-0.291.16-0.874.89-0.87-3.18-0.73-0.73-0.090.111.12-0.330-0.73-0.431.950.43-0.641.692.513
-567-812.5-871.7-3,613.4-6,902.9-2,451.9-908121585-355-1,091-45-795-381-1,4601,788-1,364-763-2,261588-605
000000000000000000000

I'rom Group Co stock margins

The I'rom Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of I'rom Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for I'rom Group Co.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the I'rom Group Co's sales revenue. A higher gross margin percentage indicates that the I'rom Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the I'rom Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the I'rom Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the I'rom Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the I'rom Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the I'rom Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

I'rom Group Co Margin History

I'rom Group Co Gross marginI'rom Group Co Profit marginI'rom Group Co EBIT marginI'rom Group Co Profit margin
2026e42.31 %0 %14.75 %
2025e42.31 %0 %14.48 %
202442.31 %6.39 %7.98 %
202349.4 %19.83 %13.85 %
202246.14 %17.61 %12.5 %
202134.32 %8.28 %10.64 %
202040.22 %11.39 %11.67 %
201938.33 %11.52 %8.62 %
201840.73 %12.11 %18.07 %
201736.85 %4.34 %4.17 %
201627.25 %-11.67 %-21.1 %
201520.05 %-18.67 %-14.66 %
201426.68 %-10.02 %-7.33 %
201331.35 %5.5 %26.12 %
201223.86 %-3.93 %-3.3 %
201127.58 %2.45 %1.62 %
201028.15 %-1.15 %-5.29 %
200929.79 %0.39 %-75.18 %
200829.05 %-1.83 %-6.79 %
200725.42 %-8.63 %-1.13 %
200629.14 %1.69 %1.11 %
200538.28 %10.99 %-1.83 %

I'rom Group Co Stock Sales Revenue, EBIT, Earnings per Share

The I'rom Group Co earnings per share therefore indicates how much revenue I'rom Group Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue I'rom Group Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates I'rom Group Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of I'rom Group Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating I'rom Group Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

I'rom Group Co Revenue, EBIT and net profit per share

DateI'rom Group Co Sales per ShareI'rom Group Co EBIT per shareI'rom Group Co Earnings per Share
2026e1,302.01 undefined0 undefined192.01 undefined
2025e1,261.61 undefined0 undefined182.73 undefined
20241,465.2 undefined93.66 undefined116.87 undefined
20231,516.17 undefined300.66 undefined210.02 undefined
20221,297.39 undefined228.51 undefined162.12 undefined
20211,070.9 undefined88.62 undefined113.93 undefined
2020893.56 undefined101.81 undefined104.26 undefined
2019877.82 undefined101.16 undefined75.68 undefined
2018731.12 undefined88.54 undefined132.13 undefined
2017448.14 undefined19.43 undefined18.7 undefined
2016387.67 undefined-45.23 undefined-81.79 undefined
2015403.06 undefined-75.27 undefined-59.08 undefined
2014401.1 undefined-40.2 undefined-29.4 undefined
2013744.89 undefined41 undefined194.56 undefined
20121,224.22 undefined-48.11 undefined-40.44 undefined
20111,554.44 undefined38.11 undefined25.11 undefined
20101,535 undefined-17.67 undefined-81.22 undefined
20091,608.67 undefined6.33 undefined-1,209.33 undefined
20081,525.22 undefined-27.89 undefined-103.56 undefined
20071,654.44 undefined-142.78 undefined-18.67 undefined
20061,236.8 undefined20.9 undefined13.7 undefined
2005510.56 undefined56.11 undefined-9.33 undefined

I'rom Group Co business model

I'rom Group Co. Ltd is a Japanese company specialized in medical services. It was founded in April 2007 and is headquartered in Tokyo, Japan. The company has become a significant player in the medical service sector in Japan within a few years. Its business model focuses on medical services and the sale of medical products, specifically in the areas of Life-Science and Clinical Research. I'rom offers support in clinical studies, distributes medications and medical devices, and provides CRM services. The company is divided into different divisions that offer various specialized products and services such as clinical research services, medical development services, corporate staffing services, and CRM services. I'rom also offers a wide range of medical products, mainly targeting the Japanese market. In conclusion, I'rom Group Co. Ltd is a leading company in the field of medical services in Japan, providing integrated support in product development and marketing for the life science and healthcare industries. I'rom Group Co is one of the most popular companies on Eulerpool.com.

I'rom Group Co SWOT Analysis

Strengths

I'rom Group Co Ltd has several strengths that contribute to its success:

  • Strong brand recognition and reputation in the market.
  • Diversified product and service portfolio catering to various healthcare needs.
  • Relevant expertise and extensive experience in the healthcare industry.
  • A well-established network of partnerships with healthcare professionals and institutions.
  • Robust financial position and stable revenue growth.

Despite its strengths, I'rom Group Co Ltd also faces certain weaknesses:

  • Reliance on a limited number of key clients for a significant portion of its revenue.
  • Higher costs compared to some competitors due to its focus on quality and innovative solutions.
  • Limited brand awareness and market penetration in certain regions.
  • Dependency on regulatory approvals for new products or services.

I'rom Group Co Ltd can leverage the following opportunities to grow and expand its business:

  • Increasing demand for advanced healthcare solutions in emerging markets.
  • Collaboration opportunities with international healthcare providers and research institutions.
  • Technological advancements offering new avenues for product development and innovation.
  • Evolving healthcare legislation and policies supporting expansion in certain regions.

I'rom Group Co Ltd should be cautious of the following threats that could negatively impact its business:

  • Intense competition from local and international healthcare companies.
  • Rapidly changing regulatory environment affecting product approvals and market access.
  • Economic downturns and fluctuations affecting consumer spending on healthcare.
  • Technological disruptions impacting traditional healthcare practices and offerings.

Weaknesses

Despite its strengths, I'rom Group Co Ltd also faces certain weaknesses:

  • Reliance on a limited number of key clients for a significant portion of its revenue.
  • Higher costs compared to some competitors due to its focus on quality and innovative solutions.
  • Limited brand awareness and market penetration in certain regions.
  • Dependency on regulatory approvals for new products or services.

I'rom Group Co Ltd can leverage the following opportunities to grow and expand its business:

  • Increasing demand for advanced healthcare solutions in emerging markets.
  • Collaboration opportunities with international healthcare providers and research institutions.
  • Technological advancements offering new avenues for product development and innovation.
  • Evolving healthcare legislation and policies supporting expansion in certain regions.

I'rom Group Co Ltd should be cautious of the following threats that could negatively impact its business:

  • Intense competition from local and international healthcare companies.
  • Rapidly changing regulatory environment affecting product approvals and market access.
  • Economic downturns and fluctuations affecting consumer spending on healthcare.
  • Technological disruptions impacting traditional healthcare practices and offerings.

Opportunities

I'rom Group Co Ltd can leverage the following opportunities to grow and expand its business:

  • Increasing demand for advanced healthcare solutions in emerging markets.
  • Collaboration opportunities with international healthcare providers and research institutions.
  • Technological advancements offering new avenues for product development and innovation.
  • Evolving healthcare legislation and policies supporting expansion in certain regions.

I'rom Group Co Ltd should be cautious of the following threats that could negatively impact its business:

  • Intense competition from local and international healthcare companies.
  • Rapidly changing regulatory environment affecting product approvals and market access.
  • Economic downturns and fluctuations affecting consumer spending on healthcare.
  • Technological disruptions impacting traditional healthcare practices and offerings.

Threats

I'rom Group Co Ltd should be cautious of the following threats that could negatively impact its business:

  • Intense competition from local and international healthcare companies.
  • Rapidly changing regulatory environment affecting product approvals and market access.
  • Economic downturns and fluctuations affecting consumer spending on healthcare.
  • Technological disruptions impacting traditional healthcare practices and offerings.

I'rom Group Co Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

I'rom Group Co historical P/E ratio, EBIT multiple, and P/S ratio

I'rom Group Co shares outstanding

The number of shares was I'rom Group Co in 2023 — This indicates how many shares 12.104 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue I'rom Group Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates I'rom Group Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of I'rom Group Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating I'rom Group Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

I'rom Group Co stock splits

In I'rom Group Co's history, there have been no stock splits.

I'rom Group Co dividend history and estimates

In 2023, I'rom Group Co paid a dividend amounting to 45 JPY. Dividend means that I'rom Group Co distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for I'rom Group Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify I'rom Group Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating I'rom Group Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

I'rom Group Co Dividend History

DateI'rom Group Co Dividend
2026e45.55 undefined
2025e45.74 undefined
202440 undefined
202345 undefined
202230 undefined
202140 undefined
202040 undefined
201930 undefined
201820 undefined
201710 undefined
200810 undefined
200710 undefined
200610 undefined
200510 undefined

I'rom Group Co dividend payout ratio

In 2023, I'rom Group Co had a payout ratio of 30.66%. The payout ratio indicates the percentage of the company's profits that I'rom Group Co distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for I'rom Group Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for I'rom Group Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate I'rom Group Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

I'rom Group Co Payout Ratio History

DateI'rom Group Co Payout ratio
2026e28.17 %
2025e25.75 %
202428.09 %
202330.66 %
202218.5 %
202135.11 %
202038.37 %
201939.64 %
201815.14 %
201753.49 %
201630.66 %
201530.66 %
201430.66 %
201330.66 %
201230.66 %
201130.66 %
201030.66 %
200930.66 %
2008-9.66 %
2007-53.59 %
200672.99 %
2005-107.18 %
Unfortunately, there are currently no price targets and forecasts available for I'rom Group Co.

I'rom Group Co shareholders

%
Name
Stocks
Change
Date
39.47801 % Mori (Toyotaka)4,779,45009/30/2023
6.81446 % Mori (Rie)825,00009/30/2023
2.00056 % Nomura Asset Management Co., Ltd.242,2001,5003/31/2024
1.01680 % Central Tanshi Co., Ltd.123,100123,1009/30/2023
0.96480 % Nikko Asset Management Co., Ltd.116,8051,3003/31/2024
0.93085 % Daiwa Asset Management Co., Ltd.112,69519912/31/2023
0.77561 % Dimensional Fund Advisors, L.P.93,90003/31/2024
0.66080 % Yabu (Taichi)80,00080,0009/30/2023
0.61950 % Mori (Ryusuke)75,00009/30/2023
0.49560 % Muramatsu (Ryoichi)60,00060,0009/30/2023
1
2
3
4

Most common questions regarding I'rom Group Co

What values and corporate philosophy does I'rom Group Co represent?

The values and corporate philosophy of I'rom Group Co Ltd revolve around three core principles. Firstly, they prioritize the health and well-being of patients by providing high-quality medical services and advanced pharmaceutical products. Secondly, they emphasize social contribution through active engagement in research and development, as well as collaborations with medical institutions. Lastly, I'rom Group Co Ltd values integrity and professionalism in their business practices, striving for transparency and accountability. With a commitment to innovation and customer-centricity, I'rom Group Co Ltd aims to improve healthcare standards and effectively meet the diverse needs of their stakeholders.

In which countries and regions is I'rom Group Co primarily present?

I'rom Group Co Ltd is primarily present in Japan.

What significant milestones has the company I'rom Group Co achieved?

Some significant milestones achieved by I'rom Group Co Ltd include expanding their presence in the healthcare industry through strategic acquisitions and partnerships, establishing a strong track record in providing comprehensive medical support services, and achieving consistent growth in revenue and market share. The company has successfully developed and launched innovative medical products and services, gaining recognition for their high-quality patient care and personalized solutions. By continuously investing in research and development, I'rom Group Co Ltd has been able to adapt to evolving market needs and remain at the forefront of the healthcare sector.

What is the history and background of the company I'rom Group Co?

I'rom Group Co Ltd is a company based in Japan that specializes in providing pharmaceutical and healthcare solutions. Established in 2002, I'rom Group Co Ltd has grown to become a leader in the healthcare industry, offering a range of services including clinical research, medical device distribution, and home care support. The company has built a strong reputation for its commitment to innovation and quality, catering to both domestic and international markets. With a strong focus on advancing healthcare solutions, I'rom Group Co Ltd continues to make significant contributions to the industry, further solidifying its position as a trusted and reliable provider in the market.

Who are the main competitors of I'rom Group Co in the market?

The main competitors of I'rom Group Co Ltd in the market include companies such as Medical Excellence JAPAN Co Ltd, HOYA Corporation, TERUMO CORPORATION, and Nipro Corporation.

In which industries is I'rom Group Co primarily active?

I'rom Group Co Ltd is primarily active in the healthcare industry and provides a wide range of medical services and solutions. The company operates and manages medical facilities, provides clinical trial support, and offers healthcare information technology systems. With a focus on patient care and healthcare innovation, I'rom Group Co Ltd plays a significant role in improving the overall healthcare ecosystem.

What is the business model of I'rom Group Co?

The business model of I'rom Group Co Ltd involves providing comprehensive healthcare services in Japan. The company operates through various segments, including Clinical Testing Business, Home Care Business, and Healthcare Support Business. I'rom Group offers clinical testing and diagnostic services, supplies medical equipment, and provides home healthcare services. They collaborate with medical institutions, pharmaceutical companies, and insurance companies to ensure high-quality care and support for patients. By offering a range of healthcare services, I'rom Group aims to improve medical accessibility and contribute to the well-being of individuals in Japan.

What is the P/E ratio of I'rom Group Co 2024?

The I'rom Group Co P/E ratio is 23.74.

What is the P/S ratio of I'rom Group Co 2024?

The I'rom Group Co P/S ratio is 1.89.

What is the Quality Investing of I'rom Group Co?

The Quality Investing for I'rom Group Co is 2/10.

What is the revenue of I'rom Group Co 2024?

The I'rom Group Co revenue is 17.74 B JPY.

How high is the profit of I'rom Group Co 2024?

The I'rom Group Co profit is 1.42 B JPY.

What is the business model of I'rom Group Co

The company I'rom Group Co Ltd is an innovative Japanese company that has been offering a wide range of health products and services since its founding in 2007. The company is headquartered in Osaka, Japan and operates branches and partner companies worldwide. The I'rom Group is divided into various business sectors, including Healthcare, Pharma, IT, and e-Commerce. In each of these sectors, the company offers a wide range of products and services tailored to the specific needs and requirements of its customers. The Healthcare sector is an important business sector for the company. Here, the company offers a wide range of products and services, including medical care, health consultation and management, diagnosis and treatment plans, as well as rehabilitation and nursing care. The company works closely with medical facilities and health organizations to ensure that their customers receive the best care and support. The Pharma sector is another important business sector for the company. Here, they offer a wide range of drugs and medications, including generics and prescription medications. The focus is on the development of medications for a variety of diseases and ailments, including cancer, cardiovascular diseases, neurological disorders, and infectious diseases. The I'rom Group takes pride in supporting their customers with high-quality products and solutions that help improve their lives and maintain their health. In the IT sector, the company offers innovative technologies and solutions aimed at improving healthcare and medical care. This includes e-health solutions, telemedicine, mobile apps, and software solutions for medical diagnosis and assessment. The company works closely with leading technology companies and research institutions to ensure that their customers always have access to the latest innovations and advances. The e-Commerce sector is the company's newest business sector, aiming to offer a wider range of health products and services online. Here, the company offers a wide range of products, including dietary supplements, medical devices, beauty products, and health services. The focus is on making the online shopping process as easy and convenient as possible to ensure that customers can enjoy the best experience and highest level of convenience. Overall, I'rom Group Co Ltd is a company dedicated to healthcare and improving the health of its customers. With innovative products, services, and technologies, the company aims to play a leading role in the healthcare industry and provide its customers with a comprehensive solution for their well-being and health.

What is the I'rom Group Co dividend?

I'rom Group Co pays a dividend of 30 JPY distributed over payouts per year.

How often does I'rom Group Co pay dividends?

The dividend cannot currently be calculated for I'rom Group Co or the company does not pay out a dividend.

What is the I'rom Group Co ISIN?

The ISIN of I'rom Group Co is JP3105170009.

What is the I'rom Group Co ticker?

The ticker of I'rom Group Co is 2372.T.

How much dividend does I'rom Group Co pay?

Over the past 12 months, I'rom Group Co paid a dividend of 40 JPY . This corresponds to a dividend yield of about 1.44 %. For the coming 12 months, I'rom Group Co is expected to pay a dividend of 45.74 JPY.

What is the dividend yield of I'rom Group Co?

The current dividend yield of I'rom Group Co is 1.44 %.

When does I'rom Group Co pay dividends?

I'rom Group Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of I'rom Group Co?

I'rom Group Co paid dividends every year for the past 10 years.

What is the dividend of I'rom Group Co?

For the upcoming 12 months, dividends amounting to 45.74 JPY are expected. This corresponds to a dividend yield of 1.65 %.

In which sector is I'rom Group Co located?

I'rom Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von I'rom Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of I'rom Group Co from 6/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did I'rom Group Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of I'rom Group Co in the year 2023?

In the year 2023, I'rom Group Co distributed 45 JPY as dividends.

In which currency does I'rom Group Co pay out the dividend?

The dividends of I'rom Group Co are distributed in JPY.

All fundamentals about I'rom Group Co

Our stock analysis for I'rom Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I'rom Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.